loader
Please Wait
Applying Filters...
Close
4

Euroapi Company Header Euroapi Company Header

X

Information, Expiry & Status of Health Canada Patents covering Vyvanse.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Gowling WLG (Canada) LLP (7)

filter

01 2527646 (7)

filter

01 LISDEXAMFETAMINE DIMESYLATE (2)

02 Lisdexamfetamine Dimesylate (5)

filter

01 CAPSULE (2)

02 Capsule (5)

filter

01 2024-06-01 (7)

Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
60 mg
Capsule
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
30 mg
Capsule
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
50 mg
Capsule
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
20 mg
Capsule
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
40 mg
Capsule
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
Oral
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
10mg
CAPSULE
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag Canada
Digital Content Digital Content
URL Supplier Web Content
2527646
70 mg
CAPSULE
Human
2024-06-01
2011-08-23
2004-06-01
VYVANSE
ORAL
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY